Today: 20 March 2026
Browse Category

OTC:FLYYQ 23 November 2025 - 7 December 2025

Spirit Airlines Stock in December 2025: What SAVEQ and FLYYQ Investors Need to Know After the Second Bankruptcy

Spirit Airlines Stock in December 2025: What SAVEQ and FLYYQ Investors Need to Know After the Second Bankruptcy

Spirit Airlines stock now trades over-the-counter under SAVEQ and FLYYQ after two Chapter 11 bankruptcies within a year. SAVEQ last changed hands near $0.47, while FLYYQ trades around $0.31 with low liquidity. The company was delisted from major exchanges after failed merger talks and ongoing financial losses. Existing shareholders are not expected to recover value under the latest restructuring plan.
Spirit Airlines Stock (FLYYQ) on November 23, 2025: Price, Second Bankruptcy, Class Actions and What Investors Need to Know

Spirit Airlines Stock (FLYYQ) on November 23, 2025: Price, Second Bankruptcy, Class Actions and What Investors Need to Know

Spirit Aviation Holdings (OTC: FLYYQ), parent of Spirit Airlines, traded at $0.25 per share Sunday, valuing the company at about $6.7 million after two Chapter 11 filings this year. Law firm Bronstein, Gewirtz & Grossman renewed calls for shareholders with losses to seek lead-plaintiff status in a class-action suit before a December 1 deadline. No new company press releases or SEC filings were issued today.

Stock Market Today

  • Centene Launches Community Programs Amid Depressed Stock Price: What Investors Should Know
    March 20, 2026, 6:30 AM EDT. Centene Corp subsidiaries have initiated community-focused programs targeting behavioral health, job training, housing support, and diabetes care, aiming to assist underserved populations across major U.S. markets. These efforts come as Centene shares (NYSE:CNC) remain under pressure, with a recent price of $35.57, down 13.7% in the past month and 40.3% over one year. Investors should monitor these initiatives closely for insights into Centene's regulatory relations and potential impact on medical loss ratios and membership retention. Despite current headwinds, the stock trades nearly 17% below analyst targets and is marked as undervalued by Simply Wall St. Key risks include rising costs without clear reimbursement or measurable health outcomes.
Go toTop